Screening for Child and Adolescent Depression in Primary Care Settings: A Systematic Evidence Review

Skip Navigation

U.S. Department of Health and Human Services

www.hhs.gov

Agency for Healthcare Research Quality

Search www.ahrq.gov

AHRQ Home | Questions? | Contact Us | Site Map | What's New | Browse | Información en español |

www.ahrq.gov

You Are Here: AHRQ Home > Clinical Information > U.S. Preventive Services Task Force (USPSTF) > Topic Index > Major Depressive Disorder in Children & Adolescents: Screening > Supporting Article

Figure 2. Response to selective serotonin reuptake inhibitors (SSRIs) to treat major depressive disorder (MDD) in randomized, controlled trials (RCTs) including children and adolescents (KQ4)

Table shows the absolute risk difference (RD) in the response rate between treatment and intervention groups for 9 SSRI trials. Go to [D] Text Description for details.

[D] Select for Text Description.

Return to Document

AHRQ

AHRQ Home | Questions? | Contact AHRQ | Site Map | Accessibility | Privacy Policy | Freedom of Information Act | Disclaimers
U.S. Department of Health & Human Services | The White House | USA.gov: The U.S. Government's Official Web Portal

Agency for Healthcare Research and Quality 540 Gaither Road Rockville, MD 20850 Telephone: (301) 427-1364